Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits
详细信息 查看全文
- 作者：Azhar Choudhry ; MD ; MBAa ; azhar.choudhry@tevapharm.com" class="auth_mail" title="E-mail the corresponding author ; Julie Mathena ; MBAa ; Jessica D. Albano ; PhD ; MPHb ; Margaret Yacovone ; MD ; MSc ; Limone Collins ; MDc
- 关键词：Respiratory illness ; Vaccination ; Adenovirus ; Retrospective ; Surveillance
- 刊名：Vaccine
- 出版年：2016
- 出版时间：31 August 2016
- 年：2016
- 卷：34
- 期：38
- 页码：4558-4564
- 全文大小：387 K
文摘
- m" id="list_l0005">
- •
A new live, oral vaccine against adenovirus type 4 and type 7 was approved in 2011.
- •
This retrospective study evaluated adverse event codes.
- •
Adverse event codes from the Defense Medical Surveillance System database were used.
- •
Data from military recruits with and without adenovirus vaccination were compared.
- •
The risk of prespecified medical events was similar between cohorts.